Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody

Clinical and Experimental Immunology

Volumn 138, Issue 2, 2004, Pages 237-244

  Takeda, Y ^a   Takeno, M ^a   Iwasaki, M ^a   Kobayashi, H ^a   Kirino, Y ^a   Ueda, A ^a   Nagahama, K ^b   Aoki, I ^b   Ishigatsubo, Yoshiaki ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Pathology ^*  (Japan)

Author keywords

Haem oxygenase 1 (HO 1); Inducible nitric oxide synthase (iNOS); Interferon gamma (IFN ); MRL lpr

Indexed keywords

ANTIBODY; AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; HEME OXYGENASE 1; HEMIN; IMMUNOGLOBULIN G; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; GLOMERULONEPHRITIS; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; SPLEEN;

ANIMALS; ANTIBODIES, ANTINUCLEAR; CELLS, CULTURED; CYTOKINES; DNA; FEMALE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HEMIN; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; KIDNEY; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MEMBRANE PROTEINS; MICE; MICE, INBRED MRL LPR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SPLEEN;

EID: 8144222061     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02594.x     Document Type: Article

References (45)

1. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37:517-54.
2. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235:1043-6.
3. Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996; 15:9-19.
4. Oberle S, Schwartz P, Abate A, Schroder H. The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate in endothelial cells. Biochem Biophys Res Commun 1999; 261:28-34.
5. Nakao A, Moore BA, Murase N et al. Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut 2003; 52:1278-85.
6. Otterbein LE, Bach FH, Alam J et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6:422-8.
7. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1. unleashing the protective properties of heme. Trends Immunol 2003; 24:449-55.
8. Morse D, Choi AM. Heme oxygenase-1: The 'emerging molecule' has arrived. Am J Respir Cell Mol Biol 2002; 27:8-16.
9. Inoue S, Suzuki M, Nagashima Y et al. Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum Gene Ther 2001; 12:967-79.
10. Hashiba T, Suzuki M, Nagashima Y, Suzuki S, Inoue S, Matsuse T, Ishigatubo Y. Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther 2001; 8:1499-507.
11. Tsuburai T, Suzuki M, Nagashima Y et al. Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway. Hum Gene Ther 2002; 13:1945-60.
12. Tsuburai T, Kaneko T, Nagashima Y, Ueda A, Tagawa A, Shinohara T, Ishigatsubo Y. Pseudomonas aeruginosa-induced neutrophilic lung inflammation is attenuated by adenovirus-mediated transfer of the heme oxygenase 1 cDNA in mice. Hum Gene Ther 2004; 15:273-85.
13. Ohta K, Yachie A, Fujimoto K et al. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J Kid Dis 2000; 35:863-70.
14. Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt MD, Rosenberg M. Induciton of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90:267-70.
15. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997; 94:10925-30.
16. Yachie A, Niida Y, Wada T et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103:129-35.
17. Shimizu H, Takahashi T, Suzuki T et al. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 2000; 28:809-17.
18. Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, Madsen K, Nick HS, Agarwal A. Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 2000; 278:F726-36.
19. Datta PK, Koukouritaki SB, Hopp KA, Lianos EA. Heme oxygenase-1 induction attenuates inducible nitric oxide synthase expression and proteinuria in glomerulonephritis. J Am Soc Nephrol 1999; 10:2540-50.
20. Mosley K, Wembridge DE, Cattell V, Cook HT. Heme oxygenase is induced in nephrotoxic nephritis and hemin, a stimulator of heme oxygenase synthesis, ameliorates disease. Kidney Int 1998; 53:672-8.
21. Magee CC, Azuma H, Knoflach A, Denton MD, Chandraker A, Iyer S, Buelow R, Sayegh M. In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide. J Am Soc Nephrol 1999; 10:1997-2005.
22. Datta PK, Gross EJ, Lianos EA. Interactions between inducible nitric oxide synthase and heme oxygenase-1 in glomerulonephritis. Kidney Int 2002; 61:847-50.
23. Reilly CM, Farrelly LW, Viti D et al. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. Kidney Int 2002; 61:839-46.
24. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37:269-390.
25. Watson ML, Rao JK, Gilkeson GS et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 1992; 176:1645-56.
26. Watanabe H, Garnier G, Circolo A et al. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol 2000; 164:786-94.
27. Morse HC III, Davidson WF, Yetter RA, Murphy ED, Roths JB, Coffman RL. Abnormalities induced by the mutant gene lpr: expansion of a unique lymphocyte subset. J Immunol 1982; 129:2612-5.
28. Kiberd BA. Interleukin-6 receptor blockage ameliorates murine lupus nephritis. J Am Soc Nephrol 1993; 4:58-61.
29. Peng SL, Moslehi J, Craft J. Roles of interferon-γ and interleukin-4 in murine lupus. J Clin Invest 1997; 99:1936-46.
30. lpr mice. J Immunol 1999; 163:6884-91.
31. Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 1996; 97:1597-604.
32. Lemay S, Mao C, Singh AK. Cytokine gene expression in the MRL/lpr model of lupus nephritis. Kidney Int 1996; 50:85-93.
33. Yamamoto K, Loskutoff DJ. Expression of transforming growth factor-beta and tumor necrosis factor-alpha in the plasma and tissues of mice with lupus nephritis. Laboratory Invest 2000; 80:1561-70.
34. Mulligan MS, Warren JS, Smith CW, Anderson DC, Yeh CG, Rudolph AR, Ward PA. Lung injury after deposition of IgA immune complexes: Requirements for CD18 and 1-arginine. J Immunol 1992; 148:3086-92.
35. Mulligan MS, Hevel JM, Marietta MA, Ward PA. Tissue injury caused by deposition of immune complexes is 1-arginine dependent. Proc Natl Acad Sci USA 1991; 88:6338-42.
36. Haas C, Ryffel B, Le Hir M. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J Immunol 1997; 158:5484-91.
37. Balomenos D, Rumold R, Theofilopoulos AN. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest 1998; 101:364-71.
38. Woo J, Iyer S, Cornejo MC, Mori N, Gao L, Sipos I, Maines M, Buelow R. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transpl Immunol 1998; 6:84-93.
39. Coito AJ, Shaw GD, Li J, Ke B, Ma J, Busuttil RW, Kupiec-Weglinski JW. Selectin-mediated interactions regulate cytokine networks and macrophage heme oxygenase-1 induction in cardiac allograft recipients. Laboratory Invest 2002; 82:61-70.
40. Weiss G, Lutton JD, Fuchs D et al. Comparative effects of heme and metalloporphyrins on interferon-γ-mediated pathways in monocytic cells (THP-1). Proc Soc Exp Biol Medical 1993; 202:470-5.
41. Yamashita K, McDaid J, Ollinger R et al. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 2004; 00:000-000. [February 20 Epub ahead of print].
42. Rokutan K, Hosokawa T, Nakamura K, Koyama K, Aoike A, Kawai K. Increased superoxide anion production and glutathione peroxidase activity in peritoneal macrophages from autoimmune-prone MRL/Mp-lpr/lpr mice. Int Arch Allergy Appl Immunol 1988; 87:113-9.
43. Blount S, Griffiths HR, Lunec J. Reactive oxygen species damage to DNA and its role in systemic lupus erythematosus. Mol Aspects Med 1991; 12:93-105.
44. Weimann BJ, Weiser H. Effects of antioxidant vitamins C, E, and beta-carotene on immune functions in MRL/lpr mice and rats. Ann NY Acad Sci 1992; 669:390-2.
45. Weimann BJ, Hermann D. Inhibition of autoimmune deterioration in MRL/lpr mice by vitamin E. Int J Vitam Nutr Res 1999; 69:255-61.